Show simple item record

dc.contributor.authorJjumba, Isaac
dc.contributor.authorKanyesigye, Micheal
dc.contributor.authorNdagijimana, Gerald
dc.contributor.authorWattira, James
dc.contributor.authorOlong, Clinton
dc.contributor.authorOlok, Rose Akumu
dc.contributor.authorBeebwa, Esther
dc.contributor.authorMuzoora, Conrad
dc.date.accessioned2023-01-31T13:25:04Z
dc.date.available2023-01-31T13:25:04Z
dc.date.issued2022
dc.identifier.citationJjumba, I., Kanyesigye, M., Ndagijimana, G., Wattira, J., Olong, C., Olok, R. A., ... & Muzoora, C. (2022). Perceived barriers and facilitators to antiretroviral therapy adherence among youth aged 15-24 years at a regional HIV clinic in South-Western Uganda: a qualitative study. African Health Sciences, 22(2), 54-62.en_US
dc.identifier.urihttp://ir.must.ac.ug/xmlui/handle/123456789/2733
dc.description.abstractIntroduction: South-Western region has the second highest HIV prevalence in Uganda. Youth aged 15-24 have shown poor adherence to antiretroviral therapy compared to the older cohorts. Previous studies from other regions have shown various barriers and facilitators. Our study was designed to describe specific barriers and facilitators to treatment adherence among youths in a large regional HIV clinic in southwestern Uganda. Methods: We used a phenomenological qualitative study design conducted amongst 30 purposively selected HIV positive youth aged 15-24 years enrolled at Mbarara Regional Referral Hospital HIV clinic on ART for a period of at least one year and 6 key informants using in-depth interviews. The data was collected in an inductive manner during the period between 21st July and 17th August 2020. The recordings were backed up, transcribed verbatim and then analyzed manually using thematic content analysis. Results: The barriers to ART adherence were described in three descending categories as perceived treatment burden, perceived resultant stigma and discrimination, whereas the main facilitators were; perceived usefulness of HIV medications, availability of free services and Social support Conclusion: Youths aged 15-24 have challenges with ART associated treatment burden and fear to disclose their HIV status because of the resultant stigma from their communities. Many have however accepted the fact that HIV medications are lifesaving and are strongly motivated to adhere to their medications despite the circumstancesen_US
dc.language.isoenen_US
dc.publisherAfrican Health Sciencesen_US
dc.subjectBarriersen_US
dc.subjectFacilitatorsen_US
dc.subjectAdherenceen_US
dc.subjectHIV/AIDSen_US
dc.subjectYoung Adultsen_US
dc.titlePerceived barriers and facilitators to antiretroviral therapy adherence among youth aged 15-24 years at a regional HIV clinic in SouthWestern Uganda: a qualitative studyen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record